ExoLuminate Study for Early Detection of Pancreatic Cancer

This study is developing a blood test that uses tiny particles called exosomes to detect pancreatic cancer at an early stage, when it is most treatable. Participants provide a blood sample, and researchers analyze the exosomes to look for cancer signals. This is a research study, not a treatment trial. **You may be eligible if...** - You are 18 or older - You meet the criteria for one of the study groups (for example, you have been diagnosed with pancreatic cancer, or you are at high risk for it) - You are able and willing to provide a blood sample **You may NOT be eligible if...** - You are pregnant - You have an active non-pancreatic cancer or are currently receiving cancer treatment (except for skin cancer) - You have had a prior organ or bone marrow transplant - You have a history of fainting or adverse reactions to blood draws Talk to your doctor to see if this trial is right for you.